Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Head and Neck Cancer

  Free Subscription


1 Ann Surg
2 BMC Cancer
2 BMC Surg
1 Clin Cancer Res
2 Clin Nucl Med
1 Int J Pediatr Otorhinolaryngol
1 Laryngoscope
19 Oral Oncol
1 Radiologia (Engl Ed)

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Surg

  1. OKUNO K, Tokunaga M, Kinugasa Y, Baba H, et al
    A Transcriptomic Liquid Biopsy Assay for Predicting Resistance to Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2022 May 13. pii: 00000658-990000000-00001.
    PubMed         Abstract available

    BMC Cancer

  2. TSAI PC, Chien HC, Hsu PK, Hung JJ, et al
    Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy.
    BMC Cancer. 2022;22:637.
    PubMed         Abstract available

  3. CAO Y, Han D, Yang S, Shi Y, et al
    Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy).
    BMC Cancer. 2022;22:650.
    PubMed         Abstract available

    BMC Surg

  4. YANG Y, Ma L
    Oesophageal reconstruction with a reversed gastric conduit for a complex oesophageal cancer patient: a case report.
    BMC Surg. 2022;22:225.
    PubMed         Abstract available

  5. LIU WQ, Yang JY, Wang XH, Cai W, et al
    Analysis of factors influencing cervical lymph node metastasis of papillary thyroid carcinoma at each lateral level.
    BMC Surg. 2022;22:228.
    PubMed         Abstract available

    Clin Cancer Res

  6. SIHAG S, Nussenzweig SC, Walch HS, Hsu M, et al
    The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma.
    Clin Cancer Res. 2022;28:2669-2678.
    PubMed         Abstract available

    Clin Nucl Med

  7. SHIRI I, Vafaei Sadr A, Amini M, Salimi Y, et al
    Decentralized Distributed Multi-institutional PET Image Segmentation Using a Federated Deep Learning Framework.
    Clin Nucl Med. 2022 Apr 20. pii: 00003072-990000000-00095.
    PubMed         Abstract available

  8. WANG Y, Jiang L, Xu Y, Zhang X, et al
    An Unusual False-Positive Uptake of Radioiodine Caused by Breast Implants.
    Clin Nucl Med. 2022;47:646-647.
    PubMed         Abstract available

    Int J Pediatr Otorhinolaryngol

  9. SAHYOUNI G, Osterbauer B, Park S, Paik C, et al
    Incidence of thymic tissue in pediatric thyroidectomy.
    Int J Pediatr Otorhinolaryngol. 2022;158:111168.
    PubMed         Abstract available


  10. LI F, Hsueh C, Huang H, Gong H, et al
    A Nomogram to Predict Nodal Response after Induction Chemotherapy for Hypopharyngeal Carcinoma.
    Laryngoscope. 2022 Jun 14. doi: 10.1002/lary.30241.
    PubMed         Abstract available

    Oral Oncol

  11. JAYASEELAN VP, A S SG, Arumugam P
    Engineered therapeutic bacteria for the treatment of oral squamous cell carcinoma.
    Oral Oncol. 2022;130:105874.

  12. YANG X, Zhou T, Ji T, Jia H, et al
    Comment on circulatory miRNAs as therapeutic molecules for oral potentially malignant disorder and oral squamous cell carcinoma.
    Oral Oncol. 2022;130:105901.

  13. VIGARIOS E, Warnakulasuriya S, Piau A, Giraudeau N, et al
    Early detection of oral malignancies may involve the development of tele-expertise in dentistry.
    Oral Oncol. 2022;130:105904.

  14. MAZEROLLE P, Fuchsmann C, Schultz P, Benmoussa N, et al
    Salvage total glossectomy and total glosso-laryngectomy: Are they worth it? A GETTEC French multicenter study.
    Oral Oncol. 2022;130:105896.
    PubMed         Abstract available

  15. DOLL C, Mrosk F, Wuester J, Runge AS, et al
    Pattern of cervical lymph node metastases in squamous cell carcinoma of the upper oral cavity - How to manage the neck.
    Oral Oncol. 2022;130:105898.
    PubMed         Abstract available

  16. TANG R, Mao S, Liu S, Li Z, et al
    Types of endoscopic surgical approaches for benign parapharyngeal space tumors.
    Oral Oncol. 2022;130:105875.

  17. MA P, Shen HY, Chen DS, Lu ZY, et al
    Anti-PD-1 plus anti-HER2 and chemotherapy showed superior and durable clinical benefit in a patient with advanced salivary duct carcinoma.
    Oral Oncol. 2022;130:105905.

  18. KIONG KL, Moreno A, Vu CN, Zheng G, et al
    Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival.
    Oral Oncol. 2022;130:105906.
    PubMed         Abstract available

  19. LOW SK, Reed CT, Millo C, Turkbey EB, et al
    Cecal mass: An unusual site of metastasis from HPV-associated oropharyngeal cancer.
    Oral Oncol. 2022;130:105928.

  20. SHIAO JC, Holt D, Ladbury C, Gao D, et al
    The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2022;130:105907.
    PubMed         Abstract available

  21. SELVAKUMAR SC, K Auxzilia P, Dinesh Y, Senthilmurugan M, et al
    MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma.
    Oral Oncol. 2022;130:105925.

  22. KIL WJ
    Rapid physical and emotional palliation from QUAD shot radiotherapy to a frail elderly patient with stage IV parotid gland cancer-associated facial paralysis and pain when no other palliative intervention was available during COVID-19 pandemic.
    Oral Oncol. 2022;130:105930.

  23. MENDONCA P, Sunny SP, Mohan U, Birur N P, et al
    Non-invasive imaging of oral potentially malignant and malignant lesions: A systematic review and meta-analysis.
    Oral Oncol. 2022;130:105877.
    PubMed         Abstract available

    "In response to "Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia".
    Oral Oncol. 2022;130:105944.

  25. LI C, Zhang Q, Sun K, Jia H, et al
    Autofluorescence imaging as a noninvasive tool of risk stratification for malignant transformation of oral leukoplakia: A follow-up cohort study.
    Oral Oncol. 2022;130:105941.
    PubMed         Abstract available

  26. MIN Y, Feng Y, He D, Zeng X, et al
    Is Age >/= 55 years an optimal cutoff point among patients with differentiated thyroid Microcarcinoma? a preliminary study.
    Oral Oncol. 2022;130:105938.
    PubMed         Abstract available

  27. FANG Y, Peng Z, Wang Y, Gao K, et al
    Current opinions on diagnosis and treatment of adenoid cystic carcinoma.
    Oral Oncol. 2022;130:105945.
    PubMed         Abstract available

  28. JAYARAMAN S, Sekar R, Veeraraghavan VP, Raj AT, et al
    MALAT 1 a modulator of PD-1/PD-L1 regulation in oral malignancies: An emerging target in cancer therapy.
    Oral Oncol. 2022;130:105950.

  29. KAZEMIAN E, Solinski M, Adams W, Moore M, et al
    The role of perineural invasion in parotid malignancy outcomes: A systematic review and meta-analysis.
    Oral Oncol. 2022;130:105937.
    PubMed         Abstract available

    Radiologia (Engl Ed)

  30. CORTAZAR-GARCIA R, Martin-Escalante MD, Robles-Cabeza L, Martinez-Santos C, et al
    Usefulness of ultrasound-guided core biopsy in thyroid nodules with inconclusive fine-needle aspiration biopsy findings.
    Radiologia (Engl Ed). 2022;64:195-205.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.